8-K
Current Report
NRX Pharmaceuticals, Inc. Filed Acc 0001104659-23-030356
Material agreement · Regulation FD disclosure
- Item 1.01 Entry into a material definitive agreement
- Item 7.01 Regulation FD disclosure
From the SEC's structured data for this filing
Loading tm238149d1_8k.htm…